| 000 | 01631 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517130459.0 | ||
| 264 | 0 | _c20170726 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1523-1747 | ||
| 024 | 7 |
_a10.1016/j.jid.2016.10.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilliams, Hywel C | |
| 245 | 0 | 0 |
_aSurgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. _h[electronic resource] |
| 260 |
_bThe Journal of investigative dermatology _c03 2017 |
||
| 300 |
_a614-619 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAminoquinolines _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Basal Cell _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImiquimod |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBath-Hextall, Fiona | |
| 700 | 1 | _aOzolins, Mara | |
| 700 | 1 | _aArmstrong, Sarah J | |
| 700 | 1 | _aColver, Graham B | |
| 700 | 1 | _aPerkins, William | |
| 700 | 1 | _aMiller, Paul S J | |
| 773 | 0 |
_tThe Journal of investigative dermatology _gvol. 137 _gno. 3 _gp. 614-619 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jid.2016.10.019 _zAvailable from publisher's website |
| 999 |
_c26679023 _d26679023 |
||